This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Frank, N. Y. Articles by Frank, M. H. Search for Related Content PubMed PubMed Citation Articles by Frank, N. Y. Articles by Frank, M. H.

ABCB5-Mediated Doxorubicin Transport and Chemoresistance in Human Malignant Melanoma

¹ Department of Genetics, Children's Hospital Boston and ² Transplantation Research Center, Brigham and Women's Hospital and Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts; ³ Program in Pharmacogenomics, Department of Pharmacology, The Ohio State University, Columbus, Ohio; and ⁴ Department of Surgery, University of Würzburg Medical School, Würzburg, Germany

Requests for reprints: Markus H. Frank, Transplantation Research Center, Brigham and Women's Hospital and Children's Hospital Boston, Harvard Medical School, 75 Francis Street, Boston, MA 02115. Phone: 617-919-2993; Fax: 617-730-0129; E-mail: mfrank{at}rics.bwh.harvard.edu.

Enhanced drug efflux mediated by ABCB1 P-glycoprotein and related ATP-binding cassette transporters is one of several mechanisms of multidrug resistance thought to impair chemotherapeutic success in human cancers. In malignant melanoma, its potential contribution to chemoresistance is uncertain. Here, we show that ABCB5, which functions as a determinant of membrane potential and regulator of cell fusion in physiologic skin progenitor cells, is expressed in clinical malignant melanoma tumors and preferentially marks a subset of hyperpolarized, CD133⁺ stem cell phenotype-expressing tumor cells in malignant melanoma cultures and clinical melanomas. We found that ABCB5 blockade significantly reversed resistance of G3361 melanoma cells to doxorubicin, an agent to which clinical melanomas have been found refractory, resulting in a 43% reduction in the LD₅₀ from 4 to 2.3 µmol/L doxorubicin (P < 0.05). Our results identified ABCB5-mediated doxorubicin efflux transport as the underlying mechanism of resistance, because ABCB5 blockade significantly enhanced intracellular drug accumulation. Consistent with this novel ABCB5 function and mechanism in doxorubicin resistance, gene expression levels of the transporter across a panel of human cancer cell lines used by the National Cancer Institute for drug screening correlated significantly with tumor resistance to doxorubicin (r = 0.44; P = 0.016). Our results identify ABCB5 as a novel drug transporter and chemoresistance mediator in human malignant melanoma. Moreover, our findings show that ABCB5 is a novel molecular marker for a distinct subset of chemoresistant, stem cell phenotype-expressing tumor cells among melanoma bulk populations and indicate that these chemoresistant cells can be specifically targeted via ABCB5 to enhance cytotoxic efficacy.

This article has been cited by other articles:

				G. Pietra, C. Manzini, M. Vitale, M. Balsamo, E. Ognio, M. Boitano, P. Queirolo, L. Moretta, and M. C. Mingari Natural killer cells kill human melanoma cells with characteristics of cancer stem cells Int. Immunol., July 1, 2009; 21(7): 793 - 801. [Abstract] [Full Text] [PDF]

				S. Rutella, G. Bonanno, A. Procoli, A. Mariotti, M. Corallo, M. G. Prisco, A. Eramo, C. Napoletano, D. Gallo, A. Perillo, et al. Cells with Characteristics of Cancer Stem/Progenitor Cells Express the CD133 Antigen in Human Endometrial Tumors Clin. Cancer Res., July 1, 2009; 15(13): 4299 - 4311. [Abstract] [Full Text] [PDF]

				C. C. Jiang, Z. G. Mao, K. A. Avery-Kiejda, M. Wade, P. Hersey, and X. D. Zhang Glucose-regulated protein 78 antagonizes cisplatin and adriamycin in human melanoma cells Carcinogenesis, February 1, 2009; 30(2): 197 - 204. [Abstract] [Full Text] [PDF]

				I. L. BOTCHKINA, R. A. ROWEHL, D. E. RIVADENEIRA, M. S. KARPEH JR., H. CRAWFORD, A. DUFOUR, J. JU, Y. WANG, Y. LEYFMAN, and G. I. BOTCHKINA Phenotypic Subpopulations of Metastatic Colon Cancer Stem Cells: Genomic Analysis Cancer Genomics Proteomics, January 1, 2009; 6(1): 19 - 29. [Abstract] [Full Text] [PDF]

				A. M. Elliott and M. A. Al-Hajj ABCB8 Mediates Doxorubicin Resistance in Melanoma Cells by Protecting the Mitochondrial Genome Mol. Cancer Res., January 1, 2009; 7(1): 79 - 87. [Abstract] [Full Text] [PDF]

				C. Hu, H. Li, J. Li, Z. Zhu, S. Yin, X. Hao, M. Yao, S. Zheng, and J. Gu Analysis of ABCG2 expression and side population identifies intrinsic drug efflux in the HCC cell line MHCC-97L and its modulation by Akt signaling Carcinogenesis, December 1, 2008; 29(12): 2289 - 2297. [Abstract] [Full Text] [PDF]

				A. Sekulic, P. Haluska Jr, A. J. Miller, J. G. De Lamo, S. Ejadi, J. S. Pulido, D. R. Salomao, E. C. Thorland, R. G. Vile, D. L. Swanson, et al. Malignant Melanoma in the 21st Century: The Emerging Molecular Landscape Mayo Clin. Proc., July 1, 2008; 83(7): 825 - 846. [Abstract] [Full Text] [PDF]

				S. E. Zabierowski and M. Herlyn Melanoma Stem Cells: The Dark Seed of Melanoma J. Clin. Oncol., June 10, 2008; 26(17): 2890 - 2894. [Abstract] [Full Text] [PDF]

				R. P. Hill and R. Perris "Destemming" Cancer Stem Cells J Natl Cancer Inst, October 3, 2007; 99(19): 1435 - 1440. [Abstract] [Full Text] [PDF]

				Y. Suryo Rahmanto, L.L. Dunn, and D.R. Richardson Identification of distinct changes in gene expression after modulation of melanoma tumor antigen p97 (melanotransferrin) in multiple models in vitro and in vivo Carcinogenesis, October 1, 2007; 28(10): 2172 - 2183. [Abstract] [Full Text] [PDF]

				V. Sharma, C. Joseph, S. Ghosh, A. Agarwal, M. K. Mishra, and E. Sen Kaempferol induces apoptosis in glioblastoma cells through oxidative stress Mol. Cancer Ther., September 1, 2007; 6(9): 2544 - 2553. [Abstract] [Full Text] [PDF]

				L. Chin, L. A. Garraway, and D. E. Fisher Malignant melanoma: genetics and therapeutics in the genomic era. Genes & Dev., August 15, 2006; 20(16): 2149 - 2182. [Abstract] [Full Text] [PDF]